PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Tobramycin (Systemic)
Presentation Product Chemical substance Chapter Items dispensed
Tobramycin 80mg/2ml solution for injection vials
0501040U0AAACAC
Tobramycin (Systemic) Tobramycin Infections 109
Tobramycin 300mg/5ml nebuliser liquid ampoules
0501040U0AAAGAG
Tobramycin (Systemic) Tobramycin Infections 81
Tobramycin 300mg/4ml nebuliser liquid ampoules
0501040U0AAAKAK
Tobramycin (Systemic) Tobramycin Infections 32
Tobramycin 40mg/1ml solution for injection vials
0501040U0AAABAB
Tobramycin (Systemic) Tobramycin Infections 4
Tobramycin 28mg inhalation powder capsules with device
0501040U0AAALAL
Tobramycin (Systemic) Tobramycin Infections 3
Tobramycin 40mg/5ml oral solution
0501040U0AAAHAH
Tobramycin (Systemic) Tobramycin Infections 2
Tobramycin 170mg/1.7ml nebuliser liquid ampoules
0501040U0AAANAN
Tobramycin (Systemic) Tobramycin Infections No data available
Tobramycin 20mg/2ml solution for injection vials
0501040U0AAAAAA
Tobramycin (Systemic) Tobramycin Infections No data available
Tobramycin 20mg/5ml oral solution
0501040U0AAAMAM
Tobramycin (Systemic) Tobramycin Infections No data available
Tobramycin 240mg/6ml solution for injection vials
0501040U0AAAIAI
Tobramycin (Systemic) Tobramycin Infections No data available
Tobramycin 40mg/1ml solution for injection ampoules
0501040U0AAAEAE
Tobramycin (Systemic) Tobramycin Infections No data available
Tobramycin 80mg/2ml solution for infusion ampoules
0501040U0AAAFAF
Tobramycin (Systemic) Tobramycin Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.